News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
469,954 Results
Type
Article (17309)
Company Profile (128)
Press Release (452517)
Section
Business (149437)
Career Advice (826)
Deals (25509)
Drug Delivery (31)
Drug Development (41941)
Employer Resources (73)
FDA (10334)
Job Trends (9481)
News (229661)
Policy (16585)
Tag
2024 BioCapital Digital (3)
2024 BioForest Digital (6)
2024 BioMidwest Digital (1)
2024 Bio NC Digital (4)
2024 Bio NC Standard (2)
2024 Biotech Bay Standard (8)
2024 Biotech Beach Digital (2)
2024 Biotech Beach Standard (4)
2024 Genetown Digital (1)
2024 Genetown Standard (6)
2024 Lone Star Bio Digital (4)
2024 Pharm Country Digital (3)
2024 Pharm Country Standard (2)
2025 Lone Star Bio Digital (4)
2026 BioCapital Elite (1)
2026 Biotech Bay Standard (1)
2026 Genetown Elite (1)
2026 Pharm Country Standard (1)
Academia (1404)
Accelerated approval (3)
Adcomms (3)
Allergies (43)
Alliances (39525)
ALS (37)
Alzheimer's disease (628)
Antibody-drug conjugate (ADC) (67)
Approvals (10365)
Artificial intelligence (237)
Autoimmune disease (3)
Automation (11)
Bankruptcy (187)
Best Places to Work (7697)
BIOSECURE Act (6)
Biosimilars (19)
Biotechnology (100)
Bladder cancer (29)
Brain cancer (17)
Breast cancer (138)
Cancer (1159)
Cardiovascular disease (64)
Career advice (722)
Career pathing (9)
CAR-T (100)
Cell therapy (290)
Cervical cancer (10)
Clinical research (33777)
Collaboration (622)
Compensation (231)
Complete response letters (4)
COVID-19 (1240)
CRISPR (36)
C-suite (168)
Cystic fibrosis (60)
Data (1193)
Decentralized trials (1)
Denatured (18)
Depression (19)
Diabetes (112)
Diagnostics (5354)
Digital health (16)
Diversity (4)
Diversity, equity & inclusion (19)
Drug discovery (81)
Drug pricing (17)
Drug shortages (4)
Duchenne muscular dystrophy (23)
Earnings (59614)
Editorial (4)
Employer branding (11)
Employer resources (66)
Events (72782)
Executive appointments (504)
FDA (11029)
Featured Employer (29)
Fibrodysplasia Ossificans Progressiva (1)
Frontotemporal dementia (3)
Funding (511)
Gene editing (85)
Generative AI (24)
Gene therapy (174)
GLP-1 (277)
Government (1466)
Grass and pollen (2)
Guidances (28)
Healthcare (12239)
Huntington's disease (6)
IgA nephropathy (11)
Immunology and inflammation (34)
Indications (13)
Infectious disease (1315)
Inflammatory bowel disease (75)
Inflation Reduction Act (3)
Influenza (32)
Intellectual property (64)
Interviews (98)
IPO (11917)
IRA (8)
Job creations (2099)
Job search strategy (647)
Kidney cancer (6)
Labor market (11)
Layoffs (188)
Leadership (7)
Legal (4004)
Liver cancer (38)
Lung cancer (145)
Lymphoma (72)
Machine learning (2)
Management (25)
Manufacturing (177)
MASH (31)
Medical device (12144)
Medtech (12149)
Mergers & acquisitions (13978)
Metabolic disorders (266)
Multiple sclerosis (28)
NASH (7)
Neurodegenerative disease (32)
Neuropsychiatric disorders (4)
Neuroscience (866)
NextGen: Class of 2025 (4303)
Non-profit (1953)
Northern California (1601)
Now hiring (9)
Obesity (118)
Opinion (99)
Ovarian cancer (50)
Pain (51)
Pancreatic cancer (41)
Parkinson's disease (74)
Partnered (12)
Patents (140)
Patient recruitment (61)
Peanut (26)
People (42912)
Pharmaceutical (21)
Pharmacy benefit managers (1)
Phase I (11500)
Phase II (14973)
Phase III (10560)
Pipeline (790)
Podcasts (37)
Policy (28)
Postmarket research (990)
Preclinical (4957)
Press Release (72)
Prostate cancer (51)
Psychedelics (7)
Radiopharmaceuticals (194)
Rare diseases (176)
Real estate (4151)
Recruiting (27)
Regulatory (12038)
Reports (21)
Research institute (1387)
Resumes & cover letters (124)
Rett syndrome (3)
RNA editing (2)
RSV (21)
Schizophrenia (27)
Series A (88)
Series B (57)
Service/supplier (7)
Sickle cell disease (23)
Southern California (1464)
Special edition (2)
Spinal muscular atrophy (69)
Sponsored (14)
Startups (2811)
State (2)
Stomach cancer (3)
Supply chain (30)
The Weekly (18)
United States (14308)
Vaccines (327)
Venture capitalists (21)
Webinars (10)
Weight loss (47)
Women's health (17)
Worklife (2)
Date
Today (96)
Last 7 days (357)
Last 30 days (1706)
Last 365 days (22380)
2025 (5657)
2024 (23911)
2023 (28220)
2022 (37973)
2021 (40235)
2020 (38228)
2019 (31602)
2018 (23944)
2017 (23273)
2016 (22000)
2015 (26342)
2014 (19973)
2013 (16604)
2012 (17926)
2011 (18541)
2010 (17313)
Location
Africa (425)
Alabama (46)
Alaska (7)
Arizona (141)
Arkansas (11)
Asia (28292)
Australia (4788)
California (3751)
Canada (1327)
China (262)
Colorado (187)
Connecticut (178)
Delaware (56)
Europe (60262)
Florida (561)
Georgia (144)
Idaho (43)
Illinois (323)
India (15)
Indiana (182)
Iowa (5)
Japan (117)
Kansas (86)
Kentucky (13)
Louisiana (6)
Maine (58)
Maryland (506)
Massachusetts (2731)
Michigan (197)
Minnesota (301)
Mississippi (2)
Missouri (67)
Montana (28)
Nebraska (20)
Nevada (37)
New Hampshire (66)
New Jersey (1064)
New Mexico (19)
New York (1029)
North Carolina (662)
North Dakota (7)
Northern California (1601)
Ohio (130)
Oklahoma (12)
Oregon (20)
Pennsylvania (740)
Puerto Rico (7)
Rhode Island (26)
South America (658)
South Carolina (16)
South Dakota (1)
Southern California (1464)
Tennessee (69)
Texas (556)
Utah (112)
Virginia (78)
Washington D.C. (18)
Washington State (380)
West Virginia (3)
Wisconsin (42)
469,954 Results for "sensient technologies corporation".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Business
Sensient Technologies Corporation Reports Results for the Quarter Ended March 31, 2024 and Raises Full Year Guidance
Sensient Technologies Corporation, a leading provider of flavors and colors for the food, pharmaceutical, and personal care markets, reported financial results for the first quarter ended March 31, 2024.
April 26, 2024
·
16 min read
Business
Sensient Technologies Corporation Reports Results for the Quarter Ended December 31, 2023
Sensient Technologies Corporation, a leading provider of flavors and colors for the food, pharmaceutical, and personal care markets, reported financial results for the fourth quarter ended December 31, 2023.
February 8, 2024
·
22 min read
BioMidwest
Sensient Declares Dividend - Jan 19, 2024
The Board of Directors of Sensient Technologies Corporation has declared a regular quarterly cash dividend on its common stock of $0.41 per share.
January 19, 2024
·
1 min read
Press Releases
Sensient Declares Dividend - October 24, 2024
October 25, 2024
·
1 min read
BioMidwest
Sensient Announces Conference Call - Jan 26, 2024
Sensient Technologies Corporation will hold its conference call to discuss 2023 fourth quarter and year-end results at 8:30 a.m. CST on Friday, February 9, 2024.
January 26, 2024
·
1 min read
BioMidwest
Sensient Announces Conference Call - October 06, 2023
Sensient Technologies Corporation will hold its conference call to discuss 2023 third quarter results at 8:30 a.m. CDT on Friday, October 20, 2023.
October 6, 2023
·
1 min read
Business
Sensient Technologies Corporation Reports Results for the Quarter Ended March 31, 2023
Sensient Technologies Corporation reported consolidated revenue of $369.0 million in this year’s first quarter compared to $355.5 million in last year’s first quarter.
April 28, 2023
·
8 min read
BioMidwest
Sensient Announces Conference Call - July 07, 2023
Sensient Technologies Corporation will hold its conference call to discuss 2023 second quarter results at 8:30 a.m. CDT on Friday, July 21, 2023.
July 7, 2023
·
1 min read
Business
Sensient Technologies Corporation Reports Results for the Quarter Ended December 31, 2022
Sensient Technologies Corporation reported consolidated revenue of $348.7 million in this year’s fourth quarter compared to $340.4 million in last year’s fourth quarter.
February 10, 2023
·
10 min read
Business
Sensient Technologies Corporation Announces Retirement of Dr. Elaine R. Wedral from its Board of Directors
Sensient Technologies Corporation Announces Retirement of Dr. Elaine R. Wedral from its Board of Directors.
December 9, 2022
·
1 min read
1 of 46,996
Next
